510(k) · Cleared
ClearedAmistem and Quadra - Line Extension
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Medacta International · LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented
Cleared on Jun 8, 2012 as substantially equivalent to K072857 (Medacta International S.A., 2008) and 2 other predicates after a 66-day review. Its family tree reaches back 5 generations to 1994. 10 later devices descend from it.
- Decided
- Jun 8, 2012
- Review
- 66 days
- Class
- Class II
- Product code
- LZO
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 5 generations to K932481 (1994). 8 ancestors in all. 10 later devices descend from it, 2 citing it directly.
- Root · 5 generations backK932481 SL-Plus and SLR-PlusEncore Orthopedics, Inc. · 1994
- 4 generations backK001942 SL-Plus and SLR-Plus StemsPlus Orthopedics · 2000
- 3 generations backK021178 SL-Plus Lateralized StemPlus Orthopedics · 2002
- 2 generations backK072857 Total Hip Prosthesis System Quadra S + Cocrmo Femoral Ball Head +…Medacta International S.A. · 2008 · Recalled
- 1 generation backK082792 Medacta Total Hip Prosthesis System - Quadra H and R Femoral StemsMedacta International S.A. · 2008 · Recalled
- This deviceK121011 Amistem and Quadra - Line ExtensionMedacta International · 2012
- Descendant · cites it directly · 9 of its ownK173794 AMIStem-H Proximal Coating, AMIStem-P and AMIStem-P CollaredMedacta International S.A. · 2018
- Descendant · 2 generations on · 7 of its ownK181254 Quadra PMedacta International S.A. · 2018
- Descendant · 3 generations on · 6 of its ownK192827 Quadra-PMedacta International S.A. · 2020
- Descendant · 3 generations on · 1 of its ownK202730 Quadra-PMedacta International S.A. · 2020
- Descendant · 4 generations on · 1 of its ownK203041 SMS Cementless StemMedacta International S.A. · 2020
Showing 5 of 10 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 10 · See all- K173794AMIStem-H Proximal Coating, AMIStem-P and AMIStem-P CollaredMedacta International S.A. · 2018 · cites it directly9descendants
- K181254Quadra PMedacta International S.A. · 2018 · 2 generations on7descendants
- K192827Quadra-PMedacta International S.A. · 2020 · 3 generations on6descendants
- K202730Quadra-PMedacta International S.A. · 2020 · 3 generations on1descendant
- K203041SMS Cementless StemMedacta International S.A. · 2020 · 4 generations on1descendant
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −5 | K932481 | SL-Plus and SLR-Plus | Encore Orthopedics, Inc. | 1994 | — |
| −4 | K001942 | SL-Plus and SLR-Plus Stems | Plus Orthopedics | 2000 | — |
| −3 | K021178 | SL-Plus Lateralized Stem | Plus Orthopedics | 2002 | — |
| −2 | K072857 | Total Hip Prosthesis System Quadra S + Cocrmo Femoral Ball Head + Apricot | Medacta International S.A. | 2008 | 1 |
| −1 | K082792 | Medacta Total Hip Prosthesis System - Quadra H and R Femoral Stems | Medacta International S.A. | 2008 | 1 |
| 0 (this device) | K121011 | Amistem and Quadra - Line Extension | Medacta International | 2012 | — |
| +1 | K173794 | AMIStem-H Proximal Coating, AMIStem-P and AMIStem-P Collared | Medacta International S.A. | 2018 | — |
| +2 | K181254 | Quadra P | Medacta International S.A. | 2018 | — |
| +3 | K192827 | Quadra-P | Medacta International S.A. | 2020 | — |
| +3 | K202730 | Quadra-P | Medacta International S.A. | 2020 | — |
| +4 | K203041 | SMS Cementless Stem | Medacta International S.A. | 2020 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2005 | 1 | 0 |
| 2007 | 1 | 0 |
| 2010 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2018 | 2 | 0 |
| 2019 | 1 | 0 |
| 2020 | 3 | 0 |
| 2021 | 1 | 0 |
| 2022 | 1 | 0 |
| 2025 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LZO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LZO device
- #1 K192827 Quadra-Pscore 19.3 · 10 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K072857 | Total Hip Prosthesis System Quadra S + Cocrmo Femoral Ball Head + ApricotSummary page 1…21 CFR 888.3353 Class 11 Device Product Codes: LZO, MEH Predicate Devices: K072857 - Medacta Total Hip Prosthesis System- Quadra S, CoCr Ball Heads, Medacta International… | 2008 |
| * | K082792 | Medacta Total Hip Prosthesis System - Quadra H and R Femoral StemsSummary page 1…LZO, MEH Predicate Devices: K072857 - Medacta Total Hip Prosthesis System- Quadra S, CoCr Ball Heads, Medacta International K082792 - Quadra H; Quadra R, Medacta International K093944 - AMIStem H; Quadra S-H (SN), Medacta International AM… | 2008 |
| * | K093944 | Medacta Total Hip Prothesis System-Amisten H , Quadra H, Quadra SSummary page 1…ystem- Quadra S, CoCr Ball Heads, Medacta International K082792 - Quadra H; Quadra R, Medacta International K093944 - AMIStem H; Quadra S-H (SN), Medacta International AMIStem and Quadra - Line Extension 510(k) Section 5… | 2010 |
What descends from it? (10)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 18 years and passes through 4 companies; a new generation was cleared every 3.4 years on median.
- 3 of the 8 ancestors have a recall of any class.
- Of its descendants, K173794 (Medacta International S.A., 2018) has gone furthest, with 9 descendants of its own.
- 5 other devices also cite its predicate K072857.
How does its category compare?
All LZO devicesLZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.
FDA decisions per year · LZO
14in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LZO
119in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LZO
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LZO
3,244in 2025
MAUDE reports naming product code LZO, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 9 | 87 | 2 | 138 |
| 2008 | 11 | 63 | 13 | 125 |
| 2009 | 7 | 83 | 42 | 189 |
| 2010 | 15 | 78 | 0 | 394 |
| 2011 | 13 | 87 | 10 | 544 |
| 2012 | 14 | 98 | 14 | 963 |
| 2013 | 26 | 100 | 0 | 1,370 |
| 2014 | 13 | 85 | 1 | 1,477 |
| 2015 | 12 | 115 | 1 | 1,348 |
| 2016 | 10 | 177 | 9 | 1,728 |
| 2017 | 16 | 257 | 5 | 2,165 |
| 2018 | 18 | 163 | 2 | 3,133 |
| 2019 | 28 | 109 | 4 | 3,066 |
| 2020 | 18 | 112 | 3 | 1,963 |
| 2021 | 12 | 170 | 0 | 2,199 |
| 2022 | 11 | 279 | 4 | 1,985 |
| 2023 | 10 | 122 | 2 | 2,066 |
| 2024 | 11 | 111 | 1 | 2,586 |
| 2025 | 14 | 119 | 1 | 3,244 |
| 2026 | 9 | 102 | 0 | — |
What is it indicated for?
The Medacta Total Hip Prosthesis System is intended for-cementless use in total or partial hip arthroplasty and in primary or revision surgery.; Hip replacement is indicated in the following cases:
* Severely painful and/or disabled joint as a result of arthritis, traumatic arthritis, rheumatoid polyarthritis, or congenital hip dysplasia.
* Avascular necrosis of the femoral head.
* Acute traumatic fracture of the femoral head or neck.
* Failure of previous hip surgery, joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K121011 · printed Nov 6, 2026
Cite this page
510(k) Report. “K121011: Amistem and Quadra - Line Extension.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K121011
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026